Purpose: To evaluate the effect of topical citicoline, vitamin B12 and hyaluronic acid (OMK2 eye drops; Omikron Italia Srl, Italy) on the healing of corneal nerve after corneal cross-linking (CXL) treatment in patients with keratoconus (KC).
Methods: A total of 44 eyes of 22 patients with KC who underwent CXL were included in this prospective study. After CXL, one eye of these patients received OMK2 eye drop and standard post-CXL treatment (OMK2 group), while the fellow eye received only standard post-CXL treatment (control group). The following parameters were analyzed in the pre- and post-CXL procedure periods (1st, 3rd and 6th months): corneal sensitivity, tear film stability, central corneal thickness (CCT), and the corneal sub-basal nerve plexus (sbNP) parameters (including corneal nerve fiber density [CNFD], corneal nerve branch density [CNBD], corneal nerve fiber length [CNFL], corneal total branch density [CTBD], corneal nerve fiber area [CNFA], corneal nerve fiber width [CNFW]).
Results: Following CXL, a comparison of the baseline and month 6 data revealed that CNFA decreased in the control group (p < 0.001) and did not differ in the OMK2 group (p = 0.283). Other corneal sbNP parameters exhibited a decrease when comparing baseline and 6 months in each group (all p < 0.05). In addition, CCT in the OMK2 group was not significantly different between baseline and month 6 (p = 0.052). However, a decline in CCT of the control groups was observed during this specified time interval (p = 0.009). Corneal sensitivity or tear film stability parameters did not differ significantly between groups at any time point or over time within each group (all p > 0.05).
Conclusion: The use of OMK2 eye drop after CXL may provide more stable CNFA. In addition, it may also provide faster recovery in CCT.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10792-025-03433-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reversal of Diabetic Dry Eye by Topical Opioid Receptor Blockade Follows Dual Pathways.
Invest Ophthalmol Vis Sci
March 2025
Department of Neuroscience and Experimental Therapeutics, Penn State University College of Medicine, Hershey, Pennsylvania, United States.
Purpose: To determine pathways in the trigeminal ganglion and corneal epithelium that are targeted by topical naltrexone (NTX) treatment for dry eye.
Methods: NTX drops were administered topically daily for 15 days to the corneal surface of male and female adult type 1 diabetic rats. Schirmer scores and corneal sensitivity were measured at baseline, 5, 10, and 15 days.
Accommodative and binocular characteristics in myopes with age-related accommodation deficiency.
BMC Ophthalmol
March 2025
Department of Ophthalmology, Peking University Third Hospital, No 49 Huayuan North Road, Haidian District, Beijing, 100191, China.
Background: To investigate accommodative and binocular characteristics in myopic patients with age-related accommodation deficiency, and to investigate the relationship of accommodation amplitude (AA) with other accommodative and binocular parameters.
Methods: Myopic patients between 40 and 50 years old to undergo refractive surgery were enrolled. Accommodative function, including AA, positive and negative relative accommodation (PRA and NRA), accommodative response (binocular cross cylinder, BCC), and binocular accommodative facility (BAF) were examined.
AAV-IKV mediated expression of decorin inhibits EMT and fibrosis in a murine model of Glaucoma and AAV-IKV transduction in Non-Human Primates.
Sci Rep
March 2025
Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, MA, Boston, United States.
Primary open angle glaucoma (POAG) and infantile aphakic glaucoma (IAG) are significant contributors of vision loss in adults and infants respectively. Both indications are associated with fibrosis of the trabecular meshwork (TM) that attenuates aqueous humor outflow, elevated intraocular pressure (IOP) and retinal ganglion cell (RGC) death. Transforming growth factor β2 (TGFβ2) is implicated in epithelial to mesenchymal transition (EMT) in both POAG and IAG.
View Article and Find Full Text PDFAn annular corneal microneedle patch for minimally invasive ophthalmic drug delivery.
Sci Adv
March 2025
Affiliated Yueqing Hospital of Wenzhou Medical University, Wenzhou 325600, China.
Microneedles directly penetrating into the cornea inevitably cause pain, corneal structure damage, and reduced light transmittance. In this work, a minimally invasive annular microneedle (A-MN) patch was developed avoiding direct puncture into the central cornea for ophthalmic drug delivery. The feasible mechanical strength of A-MNs was achieved by adjusting the ratio of PVP-β-CD and PVA to puncture the cornea barrier.
View Article and Find Full Text PDFMetformin therapy modifies corneal neuroimmune abnormalities in people with type 2 diabetes.
Diabetologia
March 2025
School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia.
Aims/hypothesis: Diabetic peripheral neuropathy is a debilitating microvascular complication of diabetes mellitus, with limited disease-modifying therapies to date. This study aimed to assess the effect of metformin on the corneal sub-basal nerve plexus as a peripheral neuropathy outcome measure in people with type 2 diabetes.
Methods: A cohort of 36 participants with type 2 diabetes receiving metformin therapy were recruited and underwent clinical assessment, corneal confocal microscopy and nerve conduction studies.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!